Oral estrogen leads to falsely low concentrations of estradiol in a common immunoassay

OBJECTIVES: Recently, an estradiol immunoassay manufacturer (Beckman Coulter, USA) issued an ‘important product notice’ alerting clinical laboratories that their assay (Access Sensitive Estradiol) was not indicated for patients undergoing exogenous estradiol treatment. The objective of this analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Cirrincione, Lauren R, Crews, Bridgit O, Dickerson, Jane A, Krasowski, Matthew D, Rongitsch, Jessica, Imborek, Katherine L, Goldstein, Zil, Greene, Dina N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859944/
https://www.ncbi.nlm.nih.gov/pubmed/35015702
http://dx.doi.org/10.1530/EC-21-0550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859944/
https://www.ncbi.nlm.nih.gov/pubmed/35015702
http://dx.doi.org/10.1530/EC-21-0550

Ejemplares similares